🔗 Visit the ClinicalTrials.gov page for NCT00089609
Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. | Cancer Res | 1992 | 4.00 |
2 | Taxol (paclitaxel): mechanisms of action. | Ann Oncol | 1994 | 2.17 |
3 | Novel therapies for metastatic castrate-resistant prostate cancer. | J Natl Cancer Inst | 2011 | 1.98 |
4 | Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells. | Cancer Res | 1995 | 1.07 |
5 | Targeting vasculature in urologic tumors: mechanistic and therapeutic significance. | J Cell Biochem | 2008 | 0.89 |
6 | Recent progress in pharmaceutical therapies for castration-resistant prostate cancer. | Int J Mol Sci | 2013 | 0.88 |